Skip to main content
Livermore
Livermore
ZHEN

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

Holders of 5% or more of APLT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Applied Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of APLT
HolderLatest formStakeChangeFirst filedLatest filingFiling
T. Rowe Price Investment Management, Inc.13G/A14.90%21.4M shares+1.70 ppfrom 13.20%May 7, 20254 filingsNov 14, 2025SEC
Alyeska Investment Group, L.P.13G5.76%6.71M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

24 Schedule 13D and 13G filings on Applied Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on APLT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 31, 202512:29 PM ETPropel Bio Management, LLCand 4 others13G/A4.20%6.02M shares–Below 5%Dec 29, 2025SEC
Dec 15, 20255:38 PM ETAlexandria Real Estate Equities, Inc.and 2 others13G/A4.30%6.50M shares–Below 5%Dec 11, 2025SEC
Nov 14, 202512:18 PM ETT. Rowe Price Investment Management, Inc.13G/A14.90%21.4M shares+1.70 ppfrom 13.20%Sep 30, 2025SEC
Aug 14, 202512:12 PM ETT. Rowe Price Investment Management, Inc.13G/A13.20%18.7M shares+2.20 ppfrom 11.00%Jun 30, 2025SEC
Jul 29, 202511:26 AM ETVanguard Group Inc13G/A3.34%4.73M shares−1.72 ppfrom 5.06%Below 5%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A3.70%5.22M shares−4.30 ppfrom 8.00%Below 5%Jun 30, 2025SEC
May 15, 20255:46 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G/A4.10%5.57M shares−5.80 ppfrom 9.90%Below 5%Mar 31, 2025SEC
May 15, 20254:30 PM ETSchonfeld Strategic Advisors LLC13G/A3.30%4.68M shares−4.24 ppfrom 7.54%Below 5%Mar 31, 2025SEC
May 7, 202510:37 AM ETT. Rowe Price Investment Management, Inc.13G/A11.00%15.6M shares+2.10 ppfrom 8.90%Apr 30, 2025SEC
May 7, 202510:19 AM ETT. Rowe Price Investment Management, Inc.13G8.90%10.4M sharesNewMar 31, 2025SEC
Apr 30, 202510:54 AM ETVanguard Group Inc13G5.06%5.89M sharesNewMar 31, 2025SEC
Feb 14, 20256:11 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G/A9.90%11.8M shares–Dec 31, 2024SEC
Feb 14, 20254:30 PM ETAlyeska Investment Group, L.P.and 2 others13G5.76%6.71M sharesNewDec 31, 2024SEC
Feb 14, 20254:15 PM ETSchonfeld Strategic Advisors LLC13G7.54%8.77M sharesNewDec 31, 2024SEC
Feb 14, 20254:15 PM ETPerceptive Advisors LLCand 2 others13G/A2.40%2.86M shares–Below 5%Dec 31, 2024SEC
Feb 14, 20252:35 PM ETVestal Point Capital, LPand 1 other13G9.90%11.5M sharesNewDec 31, 2024SEC
Feb 14, 202511:36 AM ETJanus Henderson Group PLC13G/A0.00%35.8K shares−10.40 ppfrom 10.40%Below 5%Dec 31, 2024SEC
Feb 7, 20254:13 PM ETMorgan Stanleyand 1 other13G/A2.50%2.86M shares−5.10 ppfrom 7.60%Below 5%Jan 31, 2025SEC
Feb 5, 20255:28 PM ETBlackRock, Inc.13G/A8.00%9.30M shares–Dec 31, 2024SEC
Feb 3, 20253:30 PM ETMorgan Stanleyand 1 other13G/A7.60%8.82M shares–Dec 31, 2024SEC
Jan 27, 202512:48 PM ETFranklin Resources Incand 2 others13G/A1.70%2.00M shares−4.20 ppfrom 5.90%Below 5%Dec 31, 2024SEC
Dec 6, 202411:36 AM ETJanus Henderson Group PLCand 1 other13G/A10.40%12.1M shares–Nov 29, 2024SEC
Oct 31, 202412:42 PM ETFranklin Resources Incand 3 others13G/A5.90%6.80M shares–Sep 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Applied Therapeutics, Inc. shares.

No Form 144 notices for Applied Therapeutics, Inc. are on file.